“Cloud Exhibition” Shows the Best of Mount Huangshan at the World’s Largest Tourism Fair
On March 9, Huangshan Tourism Development Co, Ltd. (Huangshan Tourism) launched its first-ever “cloud exhibition” to showcase high-quality tourism products at the International Tourism Bourse Berlin (ITB Berlin), the world’s largest travel fair.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210311005608/en/
“Cloud exhibition” shows the best of Mount Huangshan at the world’s largest tourism fair (Photo: Business Wire)
“Huangshan is world-famous for its magical landscapes and its five 'must-sees' - peculiar pine trees, strange stones, dream-like “sea of clouds”, hot spring, and spectacular winter snow landscapes,” Mr. Zhao Hui, Vice President of Huangshan Tourism explained.
Apart from showcasing the breathtaking natural scenery, the virtual exhibition allowed Huangshan Tourism to present high-quality tourism products to exhibitors and tourism agents from around the world. The company has developed a special line of English-language tourism products tailored to the international market, featuring programs such as “Winter Overnight Stay in Huangshan,” “Photography Adventure in Colorful Huangshan,” and “Huangshan Ecological and Well-being Experience.” The cloud exhibition allowed industry professionals and budding tourists alike to taste the unique charms of Mount Huangshan from the comfort of their own homes.
In recent years, the global tourism industry has seen growing trends towards independent travel, diversification, and personalization. this means a shift to self-organized travel rather than group tours. There is growing interest in culturally-immersive experiences that allow tourists to forge deeper connections with the places they visit. Blessed with both spectacular scenery and a rich cultural heritage, the Huangshan region is well aligned with these trends. The region has been developing new ways to integrate culture and tourism in its offering to international visitors, injecting new vitality into traditional culture.
"Huangshan Tourism is focused on long-term development. Showcasing the best our region has to offer through innovative tourism products is a further step for the development of Huangshan as a major international destination and also helps to promote Chinese culture overseas,” said Mr. Zhao.
Huangshan Tourism is known as China’s top publicly-listed tourism company. Drawing on the unique resources of its home in the Mount Huangshan Scenic Area, the company offers a rich portfolio of tourism products to suit every tastes. It has developed innovative business models spanning five core sectors: scenic spots, cableways, hotels, travel agencies, and Huizhou cuisine. Huangshan Tourism has received a number of industry accolades, including being recognized as one of China’s Top 500 Service Enterprises and being awarded the National Tourism Service Quality Benchmark.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005608/en/
Contact information
Shelly Wang
info@xinhuaneteurope.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 06:25:00 EET | Press release
FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 05:31:00 EET | Press release
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig
OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 04:00:00 EET | Press release
Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl
Cessna Citation CJ3 Gen2 Enters Into Service, Delivering the Most Significant Gen2 Updates to Date8.1.2026 23:30:00 EET | Press release
The Cessna Citation CJ3 Gen2 has entered into service, setting a new standard for the Citation Gen2 family. Launch customers and longtime Citation owners Dave Mecartney and Shannon Day took delivery of their new aircraft this week. Mecartney—an experienced aviator with nearly two decades flying Citation light jets and a member of Textron Aviation’s Customer Advisory Board—helped shape the enhancements that elevate the CJ3 Gen2 experience. Key upgrades include Garmin autothrottle technology, added pilot legroom and a fully customizable cabin environment, all driven by customer feedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108455097/en/ Cessna Citation CJ3 Gen2 enters into service, delivering the most significant Gen2 updates to date (Photo credit: Textron Aviation). The Cessna Citation CJ3 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The Citation CJ3 Gen2 deliv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
